Statistics from Altmetric.com
In England, although not anticipated, a reduction in genital warts (GW) diagnoses was observed from the first years of the human papillomavirus (HPV) vaccination programme using the adjuvanted bivalent vaccine, suggesting potentially cross-protective effect of the vaccine against GW.1
In their recent publication, Checchi et al2 present results of the GW surveillance programme in England since introduction of the HPV vaccination in 2008, attributing most of the impact observed today to the switch from the bivalent to the quadrivalent …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.